My take on valuing the stock is1. Price-to-Earnings (P/E) Ratio Method
This method uses the company's earnings per share (EPS) and an appropriate industry P/E ratio. However, since the company has negative earnings (as reflected in the negative EPS), this method might not give a reliable result unless we normalise future earnings expectations.
Let’s estimate the share price based on the normalized diluted EPS (provided as 0.008 in 2023):
If we apply a reasonable P/E ratio, say 15 (a typical average for many industries), we can calculate the fair share price as:
Fair Share Price
= EPS × P/E Ratio = 0.008 × 15 = = AUD0.12
Fair Share Price=EPS×P/E Ratio=0.008×15=0.12
This would suggest a fair value of $0.12 per share based on the current normalised earnings (FY23) (FY24 awaited)
2. Price-to-Book (P/B) Ratio Method
The P/B ratio compares the market price of the stock with its book value. Book value is calculated from the balance sheet as:
Book Value per Share = Total Equity Total Shares Outstanding \text{Book Value per Share} = \frac{\text{Total Equity}}{\text{Total Shares Outstanding}}
Book Value per Share=Total Shares OutstandingTotal Equity
Using the total equity from 2023 ($627.7 million) and the total shares outstanding (504.04 million), we can calculate the book value per share:
Book Value per Share = 627.7 million 504.04 million ≈ AUD 1.25
Book Value per Share=504.04 million627.7 million ≈1.25
If we apply a typical P/B ratio of 1 (indicating the stock is priced at its book value), the fair share price would be approximately $1.25.
However, companies often trade at a P/B ratio higher or lower than 1, depending on market sentiment and growth prospects. Given the company's current challenges (such as declining revenues and negative cash flow), it might trade at a discount to book value, say 0.7:
Fair Share Price = 1.25 × 0.7 = AUD 0.875
Fair Share Price=1.25×0.7=0.875
Thus, the fair share price using the P/B method could be around $0.88.
Mostly the investors are interested in Discounted Cash Flow (DCF) and Enterprise Value (EV)/ EBITDA models . Example if we expect SP to be $2.5 then the scenario is
FCC:To estimate a $2.50 share price, the company might need to generate around $100 million to $150 million in annual free cash flow, depending on the growth assumptions and discount rate used.
The company would need to generate around $157.5 million in EBITDA to justify a $2.50 share price, assuming an EV/EBITDA multiple of 8. This means substantial improvement from its current EBITDA levels.
EV:
PE Ratio & EPS method:For the stock price to reach $2.50 using a P/E ratio, we need to estimate the earnings per share (EPS) that would support such a valuation. Hiumm needs to achieve an EPS of $0.167,
Net Income Improvement: With 504 million shares outstanding, to generate an EPS of $0.167, the company would need net income of:
Net Income=EPS×Shares Outstanding=0.167×504=84.17 million\text{Net Income} = \text{EPS} \times \text{Shares Outstanding} = 0.167 \times 504 = 84.17 \text{ million}Net Income=EPS×Shares Outstanding=0.167×504=84.17 millionThis means the company would need to generate at least $84 million in net income annually to support a $2.50 share price using the P/E method.
Areas Needing Improvement to Reach a $2.50 Share Price:
Operating Cash Flow: Significant improvements in operating cash flow through revenue growth, cost-cutting, and better working capital management.
Free Cash Flow: The company would need to generate $100 million to $150 million in annual free cash flow for a $2.50 share price under the DCF method.
EBITDA: The company would need to reach an EBITDA of $157.5 million to justify a $2.50 share price using an EV/EBITDA multiple of 8.
Net Income: To achieve an EPS of $0.167 (necessary for a $2.50 share price with a P/E ratio of 15), the company would need $84 million in net income.
Equity and Book Value: The company’s equity position needs to improve, primarily by increasing retained earnings and reducing debt, to support a higher P/B ratio and justify a $2.50 share price.
IMO ...DYOR
- Forums
- ASX - By Stock
- HUM good and bad
My take on valuing the stock is 1. Price-to-Earnings (P/E) Ratio...
Featured News
Add HUM (ASX) to my watchlist
(20min delay)
|
|||||
Last
73.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $358.9M |
Open | High | Low | Value | Volume |
72.0¢ | 73.5¢ | 72.0¢ | $140.3K | 192.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 509 | 73.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
73.5¢ | 8291 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 537 | 0.725 |
10 | 28650 | 0.720 |
5 | 32217 | 0.715 |
6 | 38310 | 0.710 |
6 | 25639 | 0.705 |
Price($) | Vol. | No. |
---|---|---|
0.730 | 21858 | 15 |
0.735 | 8151 | 5 |
0.740 | 15067 | 7 |
0.745 | 41407 | 7 |
0.750 | 22769 | 3 |
Last trade - 12.17pm 13/11/2024 (20 minute delay) ? |
Featured News
HUM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online